aMoon β Full Portfolio
51 tracked investments Β· listed companies and verified rows first
Adicet Bio develops allogeneic gamma delta CAR T cell therapies for patients with autoimmune diseases and cancer.
BiotechHealthtechMenlo Park, US
Aya Jakobovits(Executive Officer, Director)Nathan Hubbard(Executive Officer)
BoardJonathan Silverstein(Director)inCarl Gordon(Director)inFlorent Gros(Director)Erez Chimovits(Director)in
Board seatYair SchindelΒ· per SEC Form D Β· $80M raise Β· filed Oct 2019
Co-investorsForesite CapitalOrbiMedPontifax Venture CapitalQuan CapitalNovartis Venture Fund
Seer develops proteomics tools for large-scale protein analysis, including an assay, automation instrument, and analysis software for studying the proteome across human and non-human samples.
BiotechDeep TechHardwareHealthtech
Omid Farokhzad(Chair and Chief Executive Officer)in
Co-investorsSoftBank Vision FundSolasta VenturesWingMaverick Ventures
Sera Prognostics develops women's health diagnostics focused on pregnancy, including the PreTRM blood test that predicts an individual's risk of spontaneous preterm birth in singleton pregnancies and the LikeMine platform that compares pregnancy outcomes using U.S. pregnancy data.
BiotechDigital HealthFemTechHealthtechSalt Lake City, US
Douglas Fisher(Executive Officer)Jay Moyes(Executive Officer)Gregory C. Critchfield(Executive Officer, Director)Andrew A. Sauter(Executive Officer)
BoardMansoor Mirza(Director)Ryan M. Trimble(Director)
Co-investorsExcelestar VenturesOUP (Osage University Partners)UpStart VenturesVivo CapitalCatalyst Health VenturesDomain Associates
Adcytherix is a clinical-stage biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) that use approved cancer drugs as payloads combined with optimized conjugation design to overcome resistance in precision oncology.
BiotechHealthtechMedical Devices
Jack Elands(Founder & CEO)inXavier Preville(Co-founder, VP & Head of Research & Preclinical Development)inJan H.M. Schellens(Chief Medical Officer)inThierry Menguy(VP & Head of CMC Operations)inJaime Arango(Chief Financial Officer)inPaul Jackson(Chief Operating Officer)in
Co-investorsRA CapitalBpifranceAndera PartnersAngelini VenturesKurma PartnersPontifax Venture Capital+1 more
Iantrek develops micro-interventional ophthalmic surgical technologies focused on enhancing total outflow through the uveoscleral pathway to treat glaucoma.
BiotechHealthtechMedical DevicesElkins Park, US
Tsontcho Ianchulev(Executive Officer, Director)Sean Ianchulev(Founder & Chairman of the Board (CMO))Michael Haydin(Executive Officer)
BoardJeffry K Weinhuff(Director)Farrell Tyson(Director)Stephen Bloch(Director)in
Co-investorsVisionary VenturesCanaan PartnersCivilization Ventures Management, LlcFemHealth VenturesJSD Capital, LLCUS Venture Partners
Scipher Medicine is a precision immunology company that combines molecular data from autoimmune patients, protein interaction mapping, and AI to match patients with the most effective therapy for immunological diseases.
AI & Machine LearningBiotechDigital Health
Joseph Loscalzo(Founder | Physician-in-Chief, Brigham and Women's Hospital)Albert-LΓ‘szlΓ³ BarabΓ‘si(Founder | Professor, Harvard and Northeastern University)
Co-investorsKhosla VenturesB3 HoldingCobalt VenturesEcho Health VenturesHitachi VenturesOptum Ventures+1 more
Better Life Partners provides same-day medication-assisted treatment for opioid and alcohol addiction, combining counseling, community support, and medication for people in recovery.
Digital HealthHealthtechMental HealthHanover, US
Adam Groff(Executive Officer, Director)Juliana Ekong(Executive Officer, Director)Myechia Minter-Jordan(Director)Steven Kelly(Executive Officer)
Board seatYair SchindelΒ· per SEC Form D
Co-investorsF-Prime Capital.406 VenturesMaverick Ventures
BiotechBoston, US
Albert Laszlo Barabsi(Director)Marcell Veidner(Executive Officer, Director, Promoter)
BoardPeter Ruppert(Director)
Board seatTodd SoneΒ· per SEC Form D Β· $5.8M raise Β· filed Jul 2024
New York, US
KRISTIN MYERS PENG(CHIEF EXECUTIVE OFFICER AND MANAGER)BURKE WISE(VICE PRESIDENT, TREASURER, SECRETARY AND MANAGER)
BoardTREVOR PRICE(MANAGER)SEBASTIAN CALIRI(MANAGER)
Board seatYair SchindelΒ· per SEC Form D Β· $61.6M raise Β· filed Apr 2026
BiotechSan Diego, US
James Woody(Director)David Slack(Executive Officer)
BoardIvor Royston(Executive Officer, Director)Patrick Soon-Shiong(Director)Richard Ghalie(Director)
Board seatGur RoshwalbΒ· per SEC Form D Β· $40M raise Β· filed Dec 2020
BiotechHealthtechMedical DevicesBillerica, US
Brian McKelligon(Executive Officer)Garry Nolan(Director)Matthew Winkler(Director)
BoardRob Hart(Executive Officer)inRobert Shepler(Director)inThomas Raffin(Director)in
Co-investorsTelegraph Hill Partners
AltruBio develops antibody-based therapeutics for immunological and inflammatory diseases, with clinical-stage candidates (ALTB-268 and ALTB-168) targeting conditions such as ulcerative colitis, psoriatic arthritis, psoriasis, and acute graft versus host disease.
BiotechHealthtech
Co-investorsDelos CapitalRA Capital
Ayala Pharma is associated with pharmaceutical drug candidates including AL102, AL101, and BST-236; the page states that AL102 and AL101 were acquired by Immunome, Inc. in Q1 2024.
Biotech
Co-investorsIsrael Biotech Fund
Biolojic uses machine learning to design programmable human antibodies, including epitope-specific binders and multi-specific "multibodies," that act as functional switches targeting validated biological pathways.
AI & Machine LearningBiotechDeep Tech
Co-investorsOurCrowdWestern Technology Investment
BiotechSan Francisco, US
Karen McGinnis(Director)Susannah Gray(Director)Cevdet Samikoglu(Director)Joy Ghosh(Director)Arman Oruc(Secretary)Osman Kibar(President and Director)
Developer of implant technology for cartilage and osteochondral defects; sold to Smith and Nephew in 2023.
Co-investorsAccelmed PartnersPeregrine Ventures
Character Bio is a precision medicine company that integrates genomics, longitudinal clinical data, imaging, and AI-based biomarker analysis to identify genetic drivers of progressive polygenic eye diseases such as age-related macular degeneration and glaucoma.
AI & Machine LearningBiotechDigital HealthJersey City, US
Cheng Zhang(Executive Officer, Director)
BoardVivek Garipalli(Director)Nick Olsen(Director)Peter DiLaura(Director)
Co-investorsCantos VenturesCatalio Capital Management, LPDuke Capital PartnersLifeforce CapitalSanofi VenturesCatalio Capital Management+3 more
Connie Health helps older Americans choose and navigate Medicare plans by combining technology with local licensed agents, providing unbiased plan recommendations and an ongoing local care team at no cost to the user.
Digital HealthHealthtechInsurTech
Oded Eran(Co-founder)inDavid Luna(Co-founder)inMichael Scopa(Co-founder)in
Co-investorsAbstract VenturesArkitekt Venturesat.inc/HealthQuest CapitalJ-VenturesJSL Health Capital+2 more
Eleos develops AI-powered software that helps behavioral health clinicians deliver more effective care through data measurement and personalization.
AI & Machine LearningDigital HealthHealthtechMental HealthCambridge, US
Alon Joffe(Chief Executive Officer)inDror Zaide(Chief Revenue Officer)inAlon Rabinovich(Chief Technology Officer)inDenny Morrison(Chief Clinical Officer)inRaz Karmi(Chief Information Security Officer)inNoam Cohen(VP of R&D)in
Co-investorsArkin CapitalF-Prime CapitalGreenfield PartnersLool VenturesMaccabee VenturesMenlo Ventures+2 more
Lin Health provides virtual, evidence-based behavioral healthcare for people with chronic pain, using the Collaborative Care model and a technology platform to address the underlying causes of pain rather than only symptoms.
Digital HealthHealthtechMental HealthWellness & Fitness
Yehuda Kogan(Founder)in
Co-investorsSaban VenturesShoni Health VenturesViola VenturesOsage Venture PartnersProofpoint Capital
Lutris Pharma is a clinical-stage biopharmaceutical company developing LUT014, a topical B-RAF inhibitor gel intended to reduce acneiform rash and other skin side effects caused by cancer therapies such as EGFR and RAS inhibitors.
BiotechHealthtech
Co-investorsPeregrine VenturesPontifax Venture Capital
Lyfegen provides a software platform for managing value-based and outcome-based healthcare contracts and drug pricing agreements between pharmaceutical companies, health insurers (payers), and providers.
Digital HealthHealthtechSaaSBasel, CH
Girisha Fernando(Founder)inMichel Mohler(Founder)Nico Julian Mros(Founder)
Co-investorsTX Ventures
MDClone offers the ADAMS Platform, a self-service healthcare data exploration environment that lets healthcare institutions access and analyze health data for research, collaboration, and operational improvements.
AI & Machine LearningData & InfrastructureDigital Health
Co-investorsDeclaration PartnersLightspeed Venture PartnersOrbiMedViola VenturesWarburg Pincus
Biotech company that secured funding with Bootstrap Europe's support during a difficult environment for growing biotech businesses.
Co-investorsBootstrap Europe
NanoGhost develops a drug targeting platform called Nano-Ghosts (NGs), nanovesicles made from the cell membrane of mesenchymal stem cells that target cancer and inflammation sites and can carry various therapeutic loads.
BiotechDeep TechHealthtech
Marcelle Machluf(Professor (technology inventor))
BiotechCambridge, US
Jay Glenn Wohlgemuth(Executive Officer, Director)Frank Grazzini, II(Executive Officer)
BoardFredric Neville Eshelman(Director)Raymond Tabibiazar(Director)
HealthtechSan Mateo, US
Philip Ma, Ph.D.(Executive Officer, Director)Brian Koh, M.D.(Executive Officer)David Siewers(Executive Officer)Omid Farokhzad, M.D.(Director)
BoardTomer Berkovitz, Ph.D.(Director)Rajesh Garg(Director)
Co-investorsCatalio Capital Management, LPWingMaverick Ventures
Seer provides a platform for sales associates in luxury retail to create and share customized lookbooks and style recommendations with clients.
Enterprise SoftwareRetail TechSaaSSan Francisco, US
Christina Czap(Founder)inFelipe Saint-Jean(Founder)in
Co-investorsOpen Opportunity FundY Combinator
SOPHiA GENETICS provides an AI-driven, cloud-based platform (SOPHiA DDM) that analyzes genomic data to help clinicians produce actionable insights for patients with cancer and rare disorders.
AI & Machine LearningBiotechDigital Health
Co-investors360 CapitalBalderton CapitalCompoundHitachi VenturesACE & Company
Combines neuro-modulation with wireless communications and smartphone apps for effective therapy treatments.
Co-investorsLightspeed Venture PartnersLionBirdNew Rhein Healthcare Investors, LLC
Theranica develops prescription digital therapeutics for pain management, including Nerivio, a wearable device that uses remote electrical neuromodulation of upper arm nerves to trigger the body's Conditioned Pain Modulation mechanism.
Digital HealthHealthtechMedical Devices
Alon Ironi(Founder)in
Co-investorsLionBirdVivo CapitalLightspeed Venture Partners
Ultima Genomics develops genomic sequencing technology to scale omics information for advances in biology and human health improvements.
BiotechDeep TechHealthtechMedical Devices
Gilad Almogy(Founder)in
Co-investorsAndreessen HorowitzKhosla VenturesPlayground GlobalFounders FundGeneral Atlantic
Developing oncology therapeutics for viral-induced tumors; went public February 2021 (VIRX).
Co-investorsBay City CapitalLatterell Venture Partners
FDA approved AI-powered medical imaging software to enhance image quality
Co-investorsFoothill VenturesKhosla Ventures
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.